Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$525,174,574
New position
Shares Held
2,662,887
first reported quarter
Ownership
0.172%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $1,499,965,087 across 7 Drug Manufacturers - General names. AZN ranks #1 (35.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
2,662,887 | $525,174,574 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,611,826 | $364,010,189 | |
| 3 | GSK |
GSK plc
|
5,518,433 | $304,562,317 | |
| 4 | LLY |
ELI LILLY & Co
|
187,359 | $172,327,187 | |
| 5 | MRK |
Merck & Co., Inc.
|
572,467 | $68,862,055 | |
| 6 | NVO |
Novo Nordisk A S
|
1,745,580 | $64,150,065 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $878,700 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $525,174,574 | 2,662,887 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||